KUALA LUMPUR, Oct 26 (Bernama) -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has today announced the expansion of its global manufacturing facility in Kuala Lumpur, elevating Malaysia as one of the global powerhouses in the manufacture and maintenance of hearing implant sound processors.
The new expansion involves an investment of more than RM30 million to support the company’s growing demand for cochlear and acoustic hearing implants in Malaysia as well as more than 180 other countries around the world. For the last six years, Cochlear’s site in the country has created more than 270 new job opportunities.
Datuk Wira Arham Abdul Rahman, Chief Executive Officer (CEO) of the Malaysian Investment Development Authority (MIDA), stated in his welcome address, “Cochlear's decision to expand its global manufacturing footprint in Malaysia will reaffirm our position not only as an ASEAN destination for innovative and advanced manufacturing, but also as a world-leading medical devices investment destination. Cochlear has also provided a flexible approach to training local talent from the diploma level and beyond with an attractive pay system above the national minimum wage. The local talents are given the knowledge and skills that are not confined to medical devices but could also be applied in various industries.”
Dig Howitt, CEO and President of Cochlear said, “This expansion is key to our mission to help hundreds of thousands of people around the world to hear. In addition to increasing our ability to make more sound processors, the new Global Distribution Centre supports efficiencies in transporting goods, and sustainability benefits by reducing the air miles travelled between us and our suppliers. We’re very grateful for the strong support and partnership from MIDA, Malaysia’s Ministry of Health (MOH) and Association of Malaysian Medical Industries (AMMI) that has allowed us to grow in Malaysia, making Kuala Lumpur our third largest site in the Cochlear network.”
The event was also attended by a 10-year-old, Olyvia Kuan Yu Qin, from Tawau, Sabah, who was born with profound hearing loss. Olyvia’s hearing loss was diagnosed at 20 months old, and she received cochlear implants at the age of 2 years old. Olyvia said, “I was born deaf. It was a big surprise for my parents. Now I can hear and speak with the help of my cochlear implants. I had to work hard to catch up on learning to hear, but now, I love reading, drama, acting, singing, and dancing.”
The new expanded site will manufacture and maintain Cochlear’s latest and most advanced cochlear and acoustic implant sound processers. With over 300 employees, the facility which spanning the area of 50,000 square feet will include the company’s global logistics, supply chain, and information technology services. As part of Cochlear’s global target to achieve net zero carbon emissions in its operations by 2030, the manufacturing site is also powered by 100 per cent renewable energy. The initiative is aligned with the country's vision of achieving net zero emissions by 2050. Adding on to this, the Malaysia’s site is one of company’s eight global operations to oversee the design, development, manufacture and supply for the Australian-headquartered company.
In the 2021-22 fiscal year, Cochlear provided more than 40,000 hearing implants to adults and children around the world. The number of children in Malaysia who could benefit from a hearing implant may be set to rise. By 2024, the Government of Malaysia aims to implement universal newborn hearing screening in 95 per cent of public and private hospitals to identify children and determine who could benefit from an assistive hearing device. Currently, only 65 per cent of hospitals in Malaysia offer this service. In Malaysia, approximately 1,500 children are born with hearing loss every year on average.
1-3 By expanding the newborn hearing screening programme, thousands more children in Malaysia could gain the opportunity to hear and reach their full potential and enables the parents to receive the necessary support and advice needed right from the start.
4 About MIDA MIDA is the government’s principal investment promotion and development agency under the Ministry of International Trade and Industry (MITI) to oversee and drive investments into the manufacturing and services sectors in Malaysia. Headquartered in Kuala Lumpur central, MIDA has 12 regional and 21 overseas office. MIDA continues to be the strategic partner to businesses in seizing the opportunities arising from the technology revolution of this era. For more information, please visit
www.mida.gov.my and follow us on Twitter, Instagram, Facebook, LinkedIn and YouTube.
About Cochlear Limited (ASX: COH)People have always been Cochlear’s inspiration, ever since Professor Graeme Clark set out to create the first multi-channel cochlear implant after seeing his father struggle with hearing loss. Since 1981, Cochlear has provided more than 700,000 devices in more than 180 countries, helping people of all ages around the world to hear. As the global leader in implantable hearing solutions, Cochlear connects people with life’s opportunities, and welcomes them to the world’s largest hearing implant community.
Cochlear has a global workforce of close to 4,500 people, with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate future needs, investing more than AUD$2 billion to date in research and development to push the boundaries of technology and help more people hear.
www.cochlear.com References 1. World Health Organization. WHO statement on hearing loss prevalence accessed on March 1, 2020 Available from: https://www.who.int.
2. Pourarian S, Khademi B, Pishva N, Jamali A. Prevalence of hearing loss in newborns admitted to neonatal intensive care unit. Iran J Otorhinolaryngol. 2012;24:129–34.
3. Vital Statistics, Malaysia. 2021
. https://www.dosm.gov.my 4. World report on hearing. Geneva: World Health Organization; 2021. Licence: CC BYNC-SA 3.0 IGO.
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
Cochlear, Hear now. And always, Nucleus, and the elliptical logo are either trademarks or registered trademarks of the Cochlear group of companies.
© Cochlear Limited 2022. All rights reserved.
D1983280 ISS1 10 22Associated images for the media release can be found at:
https://drive.google.com/drive/folders/1x4Fk82CAo0OiYOwgui-3VZKn6xMKWrPJ?usp=sharingCaption:
Image 1 (From left to right)
YBrs. Dr. Mohd Azman Yacob, Director, Medical Development Division, Ministry of Health; His Excellency Dr. Justin Lee, Australian High Commissioner to Malaysia; YBhg. Datuk Wira Arham Abdul Rahman, Chief Executive of MIDA; and Mr. Greg Bodkin, Senior Vice President Global Supply Chain, Cochlear Ltd.
Image 2 (From left to right)
Mr. Greg Bodkin, Senior Vice President Global Supply Chain, Cochlear Ltd.; His Excellency Dr. Justin Lee, Australian High Commissioner to Malaysia; YBhg. Datuk Wira Arham Abdul Rahman, Chief Executive of MIDA; and YBrs. Dr. Mohd Azman Yacob, Director, Medical Development Division, Ministry of Health.SOURCE : Malaysian Investment Development Authority (MIDA)FOR MORE INFORMATION, PLEASE CONTACT: MIDAName : Ms. Azlina HamdanDirector of Life Sciences & Medical Technology Division
Tel : +603-2267 3791
Email : azlina@mida.gov.my
Cochlear Limited
Name : Theveena Chahil
Edelman Public Relations Worldwide Sdn Bhd
Tel : +6012-5077220
Email : Theveena.Chahil@edelman.com
--BERNAMA 
